Jul 29, 2020 - Digitalisation of SMBs could add as much as USD 216 billion to India's GDP by 2024: Study

TradeBriefs Newsletter
View online   Advertise
              from India Digital






TradeBriefs Editorial

From the Editor's Desk

'We Will Share Our Vaccine with the World.' Inside the Chinese Biotech Firm Leading the Fight Against COVID-19

During the 2002 to 2003 SARS outbreak, which claimed over 774 lives worldwide, Chinese biotech company SinoVac was the only firm to go into phase 1 vaccine trials, but the pandemic suddenly disappeared. That meant that research was discontinued at a huge loss for the firm. It wasn't entirely wasted, however. Now, 17 years later, SinoVac is able to build on that earlier work, given that COVID-19 is very similar to SARS. It and coronavirus are "like brothers," says Yin Weidong, the CEO of SinoVac.

In principle, SinoVac is a private company that owns CoronaVac as its licensed intellectual property, meaning where the vaccine is distributed should be a purely commercial decision. However, the Chinese government has contributed to the estimated one billion renminbi (about $140 million) the firm is investing in CoronaVac. This and other contributions from international NGOs currently under negotiation all come with distribution commitments attached.

In a speech to the World Health Assembly on May 18, Chinese President Xi Jinping promised to make a COVID-19 vaccine produced in China a "global public good." In reality, of course, every queue has someone at the back, meaning there will be much jostling for priority - and potentially boosting Beijing's global clout.

Continued here


TradeBriefs: What's important, not just what's popular!

Advertisers of the day

IIT Bombay-WashU Executive MBA (Batch 6): 17 classroom immersions | 15+ session topics | Drive results for your organization| Apply now!

Our advertisers help fund the daily operations of TradeBriefs. We request you to accept our promotional emails.


Byju’s: Billionaire Yuri Milner all set to invest $400 million in Indian education startup

Yuri Milner is an early backer of the largest internet firms including Alibaba, Facebook Inc. and Twitter Inc.Byju’s caters to students from kindergarten through 12th grade and has over 57 million registered users and over 3.5 million paid subscribers



Today's TradeBriefs Cartoon

India and geopolitics of TikTok

Although total digital decoupling between US and China might take a long time, if it happens at all, new rules are emerging to define terms of engagement

ICICI, Yes Bank ask BharatPe to stop taking deposits in their names

Private lenders ICICI Bank and Yes Bank have asked homegrown payments startup BharatPe to stop using their names to collect deposits.

Moviegoers may come back to cinema halls sooner than expected: BookMyShow Co-founder

Ashish Hemrajani, Co-founder of BookMyShow, is confident that the entertainment industry will weather the coronavirus crisis and come back strong.

How Covid-19 Will Affect Impact Investing In India

Geeta Goel, country director, India, of the Michael & Susan Dell Foundation, talks about the need for responsible capitalism

Over regulation of payment entities will create greater distress in India’s fintech sector

The regulation imposes compliance costs on firms, sapping resources otherwise available for productive activities, such as innovation, or raising entry barriers, thus reducing competition and incentives for innovation.

India: Cognizant bets on M As to expand digital business

It has made five digital-based acquisitions so far this year, all of which are primarily in the cloud-computing space.

Internet shutdowns, pandemic have cost Kashmir Rs 40,000 cr, 5 lakh jobs, says industry head

Kashmir Chamber of Commerce and Industry president Sheikh Ashiq Ahmad said the 2G internet currently available in the region is not enough for many businesses.

TradeBriefs Publications are read by over 10,00,000 Industry Executives
About Us  |  Advertise Privacy Policy    

You are receiving this mail because of your subscription with TradeBriefs.
Our mailing address is GF 25/39, West Patel Nagar, New Delhi 110008, India